Increasing use of elective mastectomy and contralateral prophylactic surgery among breast conservation candidates: A 14-year report from a comprehensive cancer center

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 36, Issue 4, 2013, Pages 375-380

  Dragun, Anthony E ^a   Pan, Jianmin ^a   Riley, Elizabeth C ^a   Kruse, Barbara ^a   Wilson, Mary R ^a   Rai, Shesh ^a   Jain, Dharamvir ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

breast cancer; breast conservation; contralateral prophylactic mastectomy; immediate reconstruction; mastectomy

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER PATIENT; CANCER SURGERY; CONSERVATIVE TREATMENT; ELECTIVE SURGERY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MASTECTOMY; MEDICALLY UNINSURED; PARTIAL MASTECTOMY; PROPHYLAXIS; RETROSPECTIVE STUDY; SENTINEL LYMPH NODE BIOPSY; SUBURBAN POPULATION;

ADULT; AGE FACTORS; AGED; BREAST NEOPLASMS; CANCER CARE FACILITIES; COHORT STUDIES; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; EARLY DETECTION OF CANCER; FEMALE; HUMANS; LOGISTIC MODELS; MAMMAPLASTY; MASTECTOMY, SEGMENTAL; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PATIENT SELECTION; PROGNOSIS; REGISTRIES; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SEER PROGRAM; SURGICAL PROCEDURES, ELECTIVE; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 84881026627     PISSN: 02773732     EISSN: 1537453X     Source Type: Journal    
DOI: 10.1097/COC.0b013e318248da47     Document Type: Article

References (38)

1. Fisher B, Jeong JH, Anderson S, et al. Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation. N Engl J Med. 2002;347:567-575.
2. van Dongen JA, Voogd AC, Fentiman IS, et al. Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 trial. J Natl Cancer Inst. 2000;92:1143-1150.
3. Veronesi U, Cascinelli N, Mariani L, et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med. 2002; 347:1227-1232.
4. NIH Consensus Conference. Treatment of early-stage breast cancer. JAMA. 1991;265:391-395.
5. Habermann EB, Abbott A, Parsons HM, et al. Are mastectomy rates really increasing in the United States? J Clin Oncol. 2010;28:3437-3441.
6. Lazovich D, Solomon CC, Thomas DB, et al. Breast conservation therapy in the United States following the 1990 National Institutes of Health Consensus Development Conference on the treatment of patients with early stage invasive breast carcinoma. Cancer. 1999;86:628-637.
7. Al-Refaie W, Kuerer HM, Khuwaja A, et al. Determinants of mastectomy in breast conservation therapy candidates. Am J Surg. 2005;190:602-605.
8. Celaya MO, Rees JR, Gibson JJ, et al. Travel distance and season of diagnosis affect treatment choices for women with early-stage breast cancer in a predominantly rural population (United States). Cancer Causes Control. 2006;17:851-856.
9. Craft PS, Buckingham JM, Dahlstrom JE, et al. Variation in the management of early breast cancer in rural and metropolitan centres: Implications for the organisation of rural cancer services. Breast. 2010;19:396-401.
10. Freedman RA, He Y, Winer EP, et al. Trends in racial and age disparities in definitive local therapy of early-stage breast cancer. J Clin Oncol. 2009;27:713-719.
11. Haggstrom DA, Quale C, Smith-Bindman R. Differences in the quality of breast cancer care among vulnerable populations. Cancer. 2005;104:2347-2358.
12. Hampton T. Studies address racial and geographic disparities in breast cancer treatment. JAMA. 2008;300:1641.
13. Hershman DL, Buono D, Jacobson JS, et al. Surgeon characteristics and use of breast conservation surgery in women with early stage breast cancer. Ann Surg. 2009;249:828-833.
14. Hokanson P, Seshadri R, Miller KD. Underutilization of breast-conserving therapy in a predominantly rural population: need for improved surgeon and public education. Clin Breast Cancer. 2000;1:72-76.
15. Jacobs LK, Kelley KA, Rosson GD, et al. Disparities in urban and rural mastectomy populations: the effects of patient-and county-level factors on likelihood of receipt of mastectomy. Ann Surg Oncol. 2008;15:2644-2652.
16. Katz SJ, Lantz PM, Janz NK, et al. Patterns and correlates of local therapy for women with ductal carcinoma-in-situ. J Clin Oncol. 2005;23:3001-3007.
17. Lee MC, Rogers K, Griffith K, et al. Determinants of breast conservation rates: reasons for mastectomy at a comprehensive cancer center. Breast J. 2009;15:34-40.
18. Smith GL, Xu Y, Shih YC, et al. Breast-conserving surgery in older patients with invasive breast cancer: current patterns of treatment across the United States. J Am Coll Surg. 2009;209:425-433e2.
19. Tropman SE, Ricketts TC, Paskett E, et al. Rural breast cancer treatment: evidence from the Reaching Communities for Cancer Care (REACH) project. Breast Cancer Res Treat. 1999;56:59-66.
20. Jemal A, Ward E, Thun MJ. Recent trends in breast cancer incidence rates by age and tumor characteristics among US women. Breast Cancer Res. 2007;9:R28.
21. Balch CM, Jacobs LK. Mastectomies on the rise for breast cancer: "the tide is changing". Ann Surg Oncol. 2009;16:2669-2672.
22. Gomez SL, Lichtensztajn D, Kurian AW, et al. Increasing mastectomy rates for early-stage breast cancer? Population-based trends from California. J Clin Oncol. 2010;28:e155-e157; author reply e8.
23. McGuire KP, Santillan AA, Kaur P, et al. Are mastectomies on the rise? A 13-year trend analysis of the selection of mastectomy versus breast conservation therapy in 5865 patients. Ann Surg Oncol. 2009;16:2682-2690.
24. Katipamula R, Degnim AC, Hoskin T, et al. Trends in mastectomy rates at the Mayo Clinic Rochester: effect of surgical year and preoperative magnetic resonance imaging. J Clin Oncol. 2009; 27:4082-4088.
25. Blumenthal SJ, Kagen J. MSJAMA. The effects of socioeconomic status on health in rural and urban America. JAMA. 2002;287:109.
26. Hatzell TA, Ricketts TC, Tropman SE, et al. Rural physicians' understanding of the state-of-the-art in breast, colon and rectum cancer treatment. Cancer Causes Control. 1999;10:261-267.
27. Meden T St, John-Larkin C, Hermes D, et al. MSJAMA. Relationship between travel distance and utilization of breast cancer treatment in rural northern Michigan. JAMA. 2002;287:111.
28. Schroen AT, Brenin DR, Kelly MD, et al. Impact of patient distance to radiation therapy on mastectomy use in early-stage breast cancer patients. J Clin Oncol. 2005;23:7074-7080.
29. Tuttle TM, Habermann EB, Grund EH, et al. Increasing use of contralateral prophylactic mastectomy for breast cancer patients: a trend toward more aggressive surgical treatment. J Clin Oncol. 2007;25:5203-5209.
30. Tuttle TM, Jarosek S, Habermann EB, et al. Increasing rates of contralateral prophylactic mastectomy among patients with ductal carcinoma in situ. J Clin Oncol. 2009;27:1362-1367.
31. Kollias J, Ellis IO, Elston CW, et al. Clinical and histological predictors of contralateral breast cancer. Eur J Surg Oncol. 1999;25:584-589.
32. Rosen PP, Groshen S, Kinne DW, et al. Contralateral breast carcinoma: an assessment of risk and prognosis in stage I (T1N0M0) and stage II (T1N1M0) patients with 20-year follow-up. Surgery. 1989;106:904-910.
33. Arrington AK, Jarosek SL, Virnig BA, et al. Patient and surgeon characteristics associated with increased use of contralateral prophylactic mastectomy in patients with breast cancer. Ann Surg Oncol. 2009;16:2697-2704.
34. Yao K, Stewart AK, Winchester DJ, et al. Trends in contralateral prophylactic mastectomy for unilateral cancer: a report from the National Cancer Data Base, 1998-2007. Ann Surg Oncol. 2010;17:2554-2562.
35. Kroll SS, Miller MJ, Schusterman MA, et al. Rationale for elective contralateral mastectomy with immediate bilateral reconstruction. Ann Surg Oncol. 1994;1:457-461.
36. Barton MB, West CN, Liu IL, et al. Complications following bilateral prophylactic mastectomy. J Natl Cancer Inst Monogr. 2005;35:61-66.
37. Tuttle TM. Magnetic resonance imaging and contralateral prophylactic mastectomy: the "no mas" effect? Ann Surg Oncol. 2009;16:1461-1462.
38. Gemignani ML. The new mammographic screening guidelines: what were they thinking? Obstet Gynecol. 2010;115:484-486.